338 related articles for article (PubMed ID: 30759860)
21. State of the art of Smo antagonists for cancer therapy: advances in the target receptor and new ligand structures.
Espinosa-Bustos C; Mella J; Soto-Delgado J; Salas CO
Future Med Chem; 2019 Mar; 11(6):617-638. PubMed ID: 30912670
[TBL] [Abstract][Full Text] [Related]
22. Targeting the hedgehog pathway: role in cancer and clinical implications of its inhibition.
Cohen DJ
Hematol Oncol Clin North Am; 2012 Jun; 26(3):565-88, viii. PubMed ID: 22520980
[TBL] [Abstract][Full Text] [Related]
23. Polyamine Metabolism as a Therapeutic Target inHedgehog-Driven Basal Cell Carcinomaand Medulloblastoma.
Coni S; Di Magno L; Serrao SM; Kanamori Y; Agostinelli E; Canettieri G
Cells; 2019 Feb; 8(2):. PubMed ID: 30754726
[TBL] [Abstract][Full Text] [Related]
24. Synergistic cross-talk of hedgehog and interleukin-6 signaling drives growth of basal cell carcinoma.
Sternberg C; Gruber W; Eberl M; Tesanovic S; Stadler M; Elmer DP; Schlederer M; Grund S; Roos S; Wolff F; Kaur S; Mangelberger D; Lehrach H; Hache H; Wierling C; Laimer J; Lackner P; Wiederstein M; Kasper M; Risch A; Petzelbauer P; Moriggl R; Kenner L; Aberger F
Int J Cancer; 2018 Dec; 143(11):2943-2954. PubMed ID: 29987839
[TBL] [Abstract][Full Text] [Related]
25. Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma.
Lo WW; Wunder JS; Dickson BC; Campbell V; McGovern K; Alman BA; Andrulis IL
Cancer; 2014 Feb; 120(4):537-47. PubMed ID: 24151134
[TBL] [Abstract][Full Text] [Related]
26. Hedgehog signalling in the tumourigenesis and metastasis of osteosarcoma, and its potential value in the clinical therapy of osteosarcoma.
Yao Z; Han L; Chen Y; He F; Sun B; Kamar S; Zhang Y; Yang Y; Wang C; Yang Z
Cell Death Dis; 2018 Jun; 9(6):701. PubMed ID: 29899399
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells.
Justilien V; Fields AP
Clin Cancer Res; 2015 Feb; 21(3):505-13. PubMed ID: 25646180
[TBL] [Abstract][Full Text] [Related]
28. Ligand-dependent Hedgehog pathway activation in Rhabdomyosarcoma: the oncogenic role of the ligands.
Almazán-Moga A; Zarzosa P; Molist C; Velasco P; Pyczek J; Simon-Keller K; Giralt I; Vidal I; Navarro N; Segura MF; Soriano A; Navarro S; Tirado OM; Ferreres JC; Santamaria A; Rota R; Hahn H; Sánchez de Toledo J; Roma J; Gallego S
Br J Cancer; 2017 Oct; 117(9):1314-1325. PubMed ID: 28881358
[TBL] [Abstract][Full Text] [Related]
29. Hedgehog signaling pathway as key player in liver fibrosis: new insights and perspectives.
Yang JJ; Tao H; Li J
Expert Opin Ther Targets; 2014 Sep; 18(9):1011-21. PubMed ID: 24935558
[TBL] [Abstract][Full Text] [Related]
30. The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia.
Tibes R; Al-Kali A; Oliver GR; Delman DH; Hansen N; Bhagavatula K; Mohan J; Rakhshan F; Wood T; Foran JM; Mesa RA; Bogenberger JM
J Hematol Oncol; 2015 Oct; 8():114. PubMed ID: 26483188
[TBL] [Abstract][Full Text] [Related]
31. Locally advanced and metastatic basal cell carcinoma: molecular pathways, treatment options and new targeted therapies.
Ruiz Salas V; Alegre M; Garcés JR; Puig L
Expert Rev Anticancer Ther; 2014 Jun; 14(6):741-9. PubMed ID: 24611655
[TBL] [Abstract][Full Text] [Related]
32. A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma.
Erdem GU; Sendur MA; Ozdemir NY; Yazıcı O; Zengin N
Curr Med Res Opin; 2015 Apr; 31(4):743-56. PubMed ID: 25690490
[TBL] [Abstract][Full Text] [Related]
33. Digging a hole under Hedgehog: downstream inhibition as an emerging anticancer strategy.
Di Magno L; Coni S; Di Marcotullio L; Canettieri G
Biochim Biophys Acta; 2015 Aug; 1856(1):62-72. PubMed ID: 26080084
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and biological evaluation of structurally modified isoindolinone and quinazolinone derivatives as hedgehog pathway inhibitors.
Bhattarai D; Jung JH; Han S; Lee H; Oh SJ; Ko HW; Lee K
Eur J Med Chem; 2017 Jan; 125():1036-1050. PubMed ID: 27810591
[TBL] [Abstract][Full Text] [Related]
35. Hedgehog pathway and smoothened inhibitors in cancer therapies.
Chahal KK; Parle M; Abagyan R
Anticancer Drugs; 2018 Jun; 29(5):387-401. PubMed ID: 29537987
[TBL] [Abstract][Full Text] [Related]
36. Hedgehog signaling is synergistically enhanced by nutritional deprivation and ligand stimulation in human fibroblasts of Gorlin syndrome.
Mizuochi H; Fujii K; Shiohama T; Uchikawa H; Shimojo N
Biochem Biophys Res Commun; 2015 Feb; 457(3):318-23. PubMed ID: 25576868
[TBL] [Abstract][Full Text] [Related]
37. [Sonic Hedgehog signaling pathway: from embryology to molecular targeted therapies].
Watson S; Serrate C; Vignot S
Bull Cancer; 2010 Dec; 97(12):1477-83. PubMed ID: 21220225
[TBL] [Abstract][Full Text] [Related]
38. Implication of the Hedgehog pathway in hepatocellular carcinoma.
Della Corte CM; Viscardi G; Papaccio F; Esposito G; Martini G; Ciardiello D; Martinelli E; Ciardiello F; Morgillo F
World J Gastroenterol; 2017 Jun; 23(24):4330-4340. PubMed ID: 28706416
[TBL] [Abstract][Full Text] [Related]
39. A computational study of hedgehog signalling involved in basal cell carcinoma reveals the potential and limitation of combination therapy.
Buetti-Dinh A; Jensen R; Friedman R
BMC Cancer; 2018 May; 18(1):569. PubMed ID: 29776351
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Hedgehog-dependent tumors and cancer stem cells by a newly identified naturally occurring chemotype.
Infante P; Alfonsi R; Ingallina C; Quaglio D; Ghirga F; D'Acquarica I; Bernardi F; Di Magno L; Canettieri G; Screpanti I; Gulino A; Botta B; Mori M; Di Marcotullio L
Cell Death Dis; 2016 Sep; 7(9):e2376. PubMed ID: 27899820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
